(Q48614100)

English

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.

scientific article published on 8 August 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

title

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

0 references

1 reference

ChEBI release 2020-05-28

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

author name string

Paula L McClean

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

publication date

8 August 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

published in

Neuropharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

volume

86

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

page(s)

241-258

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

Identifiers

DOI

10.1016/J.NEUROPHARM.2014.07.015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

PubMed publication ID

25107586

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25107586

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/25107586

ResearchGate publication ID

264632710

0 references

(Q48614100)

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)